Early diagnosis of rare diseases is often delayed due to limited awareness among primary care physicians and inadequate diagnostic resources. Traditional genetic tests frequently lead to repeated testing and misdiagnoses, while advanced methods like next-generation sequencing offer better results but are costly and complex. On average, it takes 7.6 years in the U.S. and 5.6 years in the U.K. for patients to receive an accurate diagnosis, leading to prolonged suffering. Raising public awareness, improving medical education, and developing new diagnostic tools are essential to addressing these challenges.
Early diagnosis of rare diseases is often delayed due to limited awareness among primary care physicians and inadequate diagnostic resources.
Read MoreAccess to effective treatment for rare diseases remains a significant challenge, with less than 5% of the 7,000-8,000 known
Read MoreThe high cost of treating rare diseases, known as "orphan diseases," creates significant barriers to access. Due to small patient populations, drug manu...
Read MoreIn India, data on the prevalence of rare diseases is scarce, with most cases identified at tertiary hospitals. This lack of epidemiological data hinders understanding
Read More© eXRna Rare. All Rights Reserved.
Designed by HTML Codex
Distributed by ThemeWagon